Blog

This morning, the U.S. Supreme Court will hear oral arguments in a case that could give a boost to the Bush Administration’s backdoor “tort reform” efforts – an increasingly transparent effort to shield industry from litigation over defective products. The issue in Wyeth v. Levine is whether the Food and Drug Administration’s labeling requirements preempt […]

Halloween—a day on which not everything is as it seems—offers a fitting occasion to ponder the possible effects of globalization on the U.S. regulatory system and its ability to protect Americans.    Globalization is a complex subject, and, like the bandages of a reanimated mummy, its ramifications could probably be unwound indefinitely.  Its proponents wax […]